Skip to main content
Top
Published in: BMC Medical Research Methodology 1/2012

Open Access 01-12-2012 | Study protocol

Learning from failure - rationale and design for a study about discontinuation of randomized trials (DISCO study)

Authors: Benjamin Kasenda, Erik B von Elm, John You, Anette Blümle, Yuki Tomonaga, Ramon Saccilotto, Alain Amstutz, Theresa Bengough, Jörg Meerpohl, Mihaela Stegert, Kari A O Tikkinen, Ignacio Neumann, Alonso Carrasco-Labra, Markus Faulhaber, Sohail Mulla, Dominik Mertz, Elie A Akl, Dirk Bassler, Jason W Busse, Ignacio Ferreira-González, Francois Lamontagne, Alain Nordmann, Rachel Rosenthal, Stefan Schandelmaier, Xin Sun, Per O Vandvik, Bradley C Johnston, Martin A Walter, Bernard Burnand, Matthias Schwenkglenks, Heiner C Bucher, Gordon H Guyatt, Matthias Briel

Published in: BMC Medical Research Methodology | Issue 1/2012

Login to get access

Abstract

Background

Randomized controlled trials (RCTs) may be discontinued because of apparent harm, benefit, or futility. Other RCTs are discontinued early because of insufficient recruitment. Trial discontinuation has ethical implications, because participants consent on the premise of contributing to new medical knowledge, Research Ethics Committees (RECs) spend considerable effort reviewing study protocols, and limited resources for conducting research are wasted. Currently, little is known regarding the frequency and characteristics of discontinued RCTs.

Methods/Design

Our aims are, first, to determine the prevalence of RCT discontinuation for specific reasons; second, to determine whether the risk of RCT discontinuation for specific reasons differs between investigator- and industry-initiated RCTs; third, to identify risk factors for RCT discontinuation due to insufficient recruitment; fourth, to determine at what stage RCTs are discontinued; and fifth, to examine the publication history of discontinued RCTs.
We are currently assembling a multicenter cohort of RCTs based on protocols approved between 2000 and 2002/3 by 6 RECs in Switzerland, Germany, and Canada. We are extracting data on RCT characteristics and planned recruitment for all included protocols. Completion and publication status is determined using information from correspondence between investigators and RECs, publications identified through literature searches, or by contacting the investigators. We will use multivariable regression models to identify risk factors for trial discontinuation due to insufficient recruitment. We aim to include over 1000 RCTs of which an anticipated 150 will have been discontinued due to insufficient recruitment.

Discussion

Our study will provide insights into the prevalence and characteristics of RCTs that were discontinued. Effective recruitment strategies and the anticipation of problems are key issues in the planning and evaluation of trials by investigators, Clinical Trial Units, RECs and funding agencies. Identification and modification of barriers to successful study completion at an early stage could help to reduce the risk of trial discontinuation, save limited resources, and enable RCTs to better meet their ethical requirements.
Appendix
Available only for authorised users
Literature
1.
go back to reference Barter PJ, Caulfield M, Eriksson M, Grundy SM, Kastelein JJ, Komajda M, Lopez-Sendon J, Mosca L, Tardif JC, Waters DD, et al: Effects of torcetrapib in patients at high risk for coronary events. N Engl J Med. 2007, 357: 2109-2122. 10.1056/NEJMoa0706628.CrossRefPubMed Barter PJ, Caulfield M, Eriksson M, Grundy SM, Kastelein JJ, Komajda M, Lopez-Sendon J, Mosca L, Tardif JC, Waters DD, et al: Effects of torcetrapib in patients at high risk for coronary events. N Engl J Med. 2007, 357: 2109-2122. 10.1056/NEJMoa0706628.CrossRefPubMed
2.
go back to reference van den Berghe G, Wouters P, Weekers F, Verwaest C, Bruyninckx F, Schetz M, Vlasselaers D, Ferdinande P, Lauwers P, Bouillon R: Intensive insulin therapy in critically ill patients. N Engl J Med. 2001, 345: 1359-1367. 10.1056/NEJMoa011300.CrossRefPubMed van den Berghe G, Wouters P, Weekers F, Verwaest C, Bruyninckx F, Schetz M, Vlasselaers D, Ferdinande P, Lauwers P, Bouillon R: Intensive insulin therapy in critically ill patients. N Engl J Med. 2001, 345: 1359-1367. 10.1056/NEJMoa011300.CrossRefPubMed
3.
go back to reference Ware JH, Muller JE, Braunwald E: The futility index. An approach to the cost-effective termination of randomized clinical trials. Am J Med. 1985, 78: 635-643. 10.1016/0002-9343(85)90407-3.CrossRefPubMed Ware JH, Muller JE, Braunwald E: The futility index. An approach to the cost-effective termination of randomized clinical trials. Am J Med. 1985, 78: 635-643. 10.1016/0002-9343(85)90407-3.CrossRefPubMed
4.
go back to reference Smith MR, Manola J, Kaufman DS, Oh WK, Bubley GJ, Kantoff PW: Celecoxib versus placebo for men with prostate cancer and a rising serum prostate-specific antigen after radical prostatectomy and/or radiation therapy. J Clin Oncol. 2006, 24: 2723-2728. 10.1200/JCO.2005.03.7804.CrossRefPubMed Smith MR, Manola J, Kaufman DS, Oh WK, Bubley GJ, Kantoff PW: Celecoxib versus placebo for men with prostate cancer and a rising serum prostate-specific antigen after radical prostatectomy and/or radiation therapy. J Clin Oncol. 2006, 24: 2723-2728. 10.1200/JCO.2005.03.7804.CrossRefPubMed
5.
go back to reference Charlson ME, Horwitz RI: Applying results of randomised trials to clinical practice: impact of losses before randomisation. Br Med J (Clin Res Ed). 1984, 289: 1281-1284. 10.1136/bmj.289.6454.1281.CrossRef Charlson ME, Horwitz RI: Applying results of randomised trials to clinical practice: impact of losses before randomisation. Br Med J (Clin Res Ed). 1984, 289: 1281-1284. 10.1136/bmj.289.6454.1281.CrossRef
7.
go back to reference Wilson S, Delaney BC, Roalfe A, Roberts L, Redman V, Wearn AM, Hobbs FD: Randomised controlled trials in primary care: case study. BMJ. 2000, 321: 24-27.CrossRefPubMedPubMedCentral Wilson S, Delaney BC, Roalfe A, Roberts L, Redman V, Wearn AM, Hobbs FD: Randomised controlled trials in primary care: case study. BMJ. 2000, 321: 24-27.CrossRefPubMedPubMedCentral
8.
go back to reference Foy R, Parry J, Duggan A, Delaney B, Wilson S, Lewin-Van Den Broek NT, Lassen A, Vickers L, Myres P: How evidence based are recruitment strategies to randomized controlled trials in primary care? Experience from seven studies. Fam Pract. 2003, 20: 83-92. 10.1093/fampra/20.1.83.CrossRefPubMed Foy R, Parry J, Duggan A, Delaney B, Wilson S, Lewin-Van Den Broek NT, Lassen A, Vickers L, Myres P: How evidence based are recruitment strategies to randomized controlled trials in primary care? Experience from seven studies. Fam Pract. 2003, 20: 83-92. 10.1093/fampra/20.1.83.CrossRefPubMed
9.
go back to reference McDonald AM, Knight RC, Campbell MK, Entwistle VA, Grant AM, Cook JA, Elbourne DR, Francis D, Garcia J, Roberts I, et al: What influences recruitment to randomised controlled trials? A review of trials funded by two UK funding agencies. Trials. 2006, 7: 9-10.1186/1745-6215-7-9.CrossRefPubMedPubMedCentral McDonald AM, Knight RC, Campbell MK, Entwistle VA, Grant AM, Cook JA, Elbourne DR, Francis D, Garcia J, Roberts I, et al: What influences recruitment to randomised controlled trials? A review of trials funded by two UK funding agencies. Trials. 2006, 7: 9-10.1186/1745-6215-7-9.CrossRefPubMedPubMedCentral
10.
go back to reference Toerien M, Brookes ST, Metcalfe C, de Salis I, Tomlin Z, Peters TJ, Sterne J, Donovan JL: A review of reporting of participant recruitment and retention in RCTs in six major journals. Trials. 2009, 10: 52-10.1186/1745-6215-10-52.CrossRefPubMedPubMedCentral Toerien M, Brookes ST, Metcalfe C, de Salis I, Tomlin Z, Peters TJ, Sterne J, Donovan JL: A review of reporting of participant recruitment and retention in RCTs in six major journals. Trials. 2009, 10: 52-10.1186/1745-6215-10-52.CrossRefPubMedPubMedCentral
11.
go back to reference Cassileth BR, Lusk EJ, Miller DS, Hurwitz S: Attitudes toward clinical trials among patients and the public. JAMA. 1982, 248: 968-970. 10.1001/jama.1982.03330080050028.CrossRefPubMed Cassileth BR, Lusk EJ, Miller DS, Hurwitz S: Attitudes toward clinical trials among patients and the public. JAMA. 1982, 248: 968-970. 10.1001/jama.1982.03330080050028.CrossRefPubMed
12.
go back to reference Mattson ME, Curb JD, McArdle R: Participation in a clinical trial: the patients' point of view. Control Clin Trials. 1985, 6: 156-167. 10.1016/0197-2456(85)90121-7.CrossRefPubMed Mattson ME, Curb JD, McArdle R: Participation in a clinical trial: the patients' point of view. Control Clin Trials. 1985, 6: 156-167. 10.1016/0197-2456(85)90121-7.CrossRefPubMed
13.
go back to reference Welton AJ, Vickers MR, Cooper JA, Meade TW, Marteau TM: Is recruitment more difficult with a placebo arm in randomised controlled trials? A quasirandomised, interview based study. BMJ. 1999, 318: 1114-1117. 10.1136/bmj.318.7191.1114.CrossRefPubMedPubMedCentral Welton AJ, Vickers MR, Cooper JA, Meade TW, Marteau TM: Is recruitment more difficult with a placebo arm in randomised controlled trials? A quasirandomised, interview based study. BMJ. 1999, 318: 1114-1117. 10.1136/bmj.318.7191.1114.CrossRefPubMedPubMedCentral
14.
go back to reference Mills E, Wilson K, Rachlis B, Griffith L, Wu P, Guyatt G, Cooper C: Barriers to participation in HIV drug trials: a systematic review. Lancet Infect Dis. 2006, 6: 32-38. 10.1016/S1473-3099(05)70324-8.CrossRefPubMed Mills E, Wilson K, Rachlis B, Griffith L, Wu P, Guyatt G, Cooper C: Barriers to participation in HIV drug trials: a systematic review. Lancet Infect Dis. 2006, 6: 32-38. 10.1016/S1473-3099(05)70324-8.CrossRefPubMed
15.
go back to reference Mills EJ, Seely D, Rachlis B, Griffith L, Wu P, Wilson K, Ellis P, Wright JR: Barriers to participation in clinical trials of cancer: a meta-analysis and systematic review of patient-reported factors. Lancet Oncol. 2006, 7: 141-148. 10.1016/S1470-2045(06)70576-9.CrossRefPubMed Mills EJ, Seely D, Rachlis B, Griffith L, Wu P, Wilson K, Ellis P, Wright JR: Barriers to participation in clinical trials of cancer: a meta-analysis and systematic review of patient-reported factors. Lancet Oncol. 2006, 7: 141-148. 10.1016/S1470-2045(06)70576-9.CrossRefPubMed
16.
go back to reference Ross S, Grant A, Counsell C, Gillespie W, Russell I, Prescott R: Barriers to participation in randomised controlled trials: a systematic review. J Clin Epidemiol. 1999, 52: 1143-1156. 10.1016/S0895-4356(99)00141-9.CrossRefPubMed Ross S, Grant A, Counsell C, Gillespie W, Russell I, Prescott R: Barriers to participation in randomised controlled trials: a systematic review. J Clin Epidemiol. 1999, 52: 1143-1156. 10.1016/S0895-4356(99)00141-9.CrossRefPubMed
17.
go back to reference Embi PJ, Jain A, Clark J, Bizjack S, Hornung R, Harris CM: Effect of a clinical trial alert system on physician participation in trial recruitment. Arch Intern Med. 2005, 165: 2272-2277. 10.1001/archinte.165.19.2272.CrossRefPubMedPubMedCentral Embi PJ, Jain A, Clark J, Bizjack S, Hornung R, Harris CM: Effect of a clinical trial alert system on physician participation in trial recruitment. Arch Intern Med. 2005, 165: 2272-2277. 10.1001/archinte.165.19.2272.CrossRefPubMedPubMedCentral
18.
go back to reference Francis D, Roberts I, Elbourne DR, Shakur H, Knight RC, Garcia J, Snowdon C, Entwistle VA, McDonald AM, Grant AM, et al: Marketing and clinical trials: a case study. Trials. 2007, 8: 37-10.1186/1745-6215-8-37.CrossRefPubMedPubMedCentral Francis D, Roberts I, Elbourne DR, Shakur H, Knight RC, Garcia J, Snowdon C, Entwistle VA, McDonald AM, Grant AM, et al: Marketing and clinical trials: a case study. Trials. 2007, 8: 37-10.1186/1745-6215-8-37.CrossRefPubMedPubMedCentral
19.
go back to reference Atherton H, Banks D, Harbit R, Long L, Chadd F, Hay P, Kerry S, Simms I, Oakeshott P: Recruitment of young women to a trial of chlamydia screening - as easy as it sounds?. Trials. 2007, 8: 41-10.1186/1745-6215-8-41.CrossRefPubMedPubMedCentral Atherton H, Banks D, Harbit R, Long L, Chadd F, Hay P, Kerry S, Simms I, Oakeshott P: Recruitment of young women to a trial of chlamydia screening - as easy as it sounds?. Trials. 2007, 8: 41-10.1186/1745-6215-8-41.CrossRefPubMedPubMedCentral
20.
go back to reference Caldwell PH, Hamilton S, Tan A, Craig JC: Strategies for increasing recruitment to randomised controlled trials: systematic review. PLoS Med. 2010, 7: e1000368-10.1371/journal.pmed.1000368.CrossRefPubMedPubMedCentral Caldwell PH, Hamilton S, Tan A, Craig JC: Strategies for increasing recruitment to randomised controlled trials: systematic review. PLoS Med. 2010, 7: e1000368-10.1371/journal.pmed.1000368.CrossRefPubMedPubMedCentral
21.
go back to reference Watson JM, Torgerson DJ: Increasing recruitment to randomised trials: a review of randomised controlled trials. BMC Med Res Methodol. 2006, 6: 34-10.1186/1471-2288-6-34.CrossRefPubMedPubMedCentral Watson JM, Torgerson DJ: Increasing recruitment to randomised trials: a review of randomised controlled trials. BMC Med Res Methodol. 2006, 6: 34-10.1186/1471-2288-6-34.CrossRefPubMedPubMedCentral
22.
go back to reference Treweek S, Pitkethly M, Cook J, Kjeldstrom M, Taskila T, Johansen M, Sullivan F, Wilson S, Jackson C, Jones R: Strategies to improve recruitment to randomised controlled trials. Cochrane Database Syst Rev. 2010, 4: MR000013-PubMed Treweek S, Pitkethly M, Cook J, Kjeldstrom M, Taskila T, Johansen M, Sullivan F, Wilson S, Jackson C, Jones R: Strategies to improve recruitment to randomised controlled trials. Cochrane Database Syst Rev. 2010, 4: MR000013-PubMed
23.
go back to reference Fletcher B, Gheorghe A, Moore D, Wilson S, Damery S: Improving the recruitment activity of clinicians in randomised controlled trials: a systematic review. BMJ Open. 2012, 2: e000496-10.1136/bmjopen-2011-000496.CrossRefPubMedPubMedCentral Fletcher B, Gheorghe A, Moore D, Wilson S, Damery S: Improving the recruitment activity of clinicians in randomised controlled trials: a systematic review. BMJ Open. 2012, 2: e000496-10.1136/bmjopen-2011-000496.CrossRefPubMedPubMedCentral
24.
go back to reference Bassler D, Briel M, Montori VM, Lane M, Glasziou P, Zhou Q, Heels-Ansdell D, Walter SD, Guyatt GH, Group S-S, et al: Stopping randomized trials early for benefit and estimation of treatment effects: systematic review and meta-regression analysis. JAMA. 2010, 303: 1180-1187. 10.1001/jama.2010.310.CrossRefPubMed Bassler D, Briel M, Montori VM, Lane M, Glasziou P, Zhou Q, Heels-Ansdell D, Walter SD, Guyatt GH, Group S-S, et al: Stopping randomized trials early for benefit and estimation of treatment effects: systematic review and meta-regression analysis. JAMA. 2010, 303: 1180-1187. 10.1001/jama.2010.310.CrossRefPubMed
25.
go back to reference Montori VM, Devereaux PJ, Adhikari NK, Burns KE, Eggert CH, Briel M, Lacchetti C, Leung TW, Darling E, Bryant DM, et al: Randomized trials stopped early for benefit: a systematic review. JAMA. 2005, 294: 2203-2209. 10.1001/jama.294.17.2203.CrossRefPubMed Montori VM, Devereaux PJ, Adhikari NK, Burns KE, Eggert CH, Briel M, Lacchetti C, Leung TW, Darling E, Bryant DM, et al: Randomized trials stopped early for benefit: a systematic review. JAMA. 2005, 294: 2203-2209. 10.1001/jama.294.17.2203.CrossRefPubMed
26.
go back to reference De Angelis C, Drazen JM, Frizelle FA, Haug C, Hoey J, Horton R, Kotzin S, Laine C, Marusic A, Overbeke AJ, et al: Clinical trial registration: a statement from the International Committee of Medical Journal Editors. Ann Intern Med. 2004, 141: 477-478.CrossRefPubMed De Angelis C, Drazen JM, Frizelle FA, Haug C, Hoey J, Horton R, Kotzin S, Laine C, Marusic A, Overbeke AJ, et al: Clinical trial registration: a statement from the International Committee of Medical Journal Editors. Ann Intern Med. 2004, 141: 477-478.CrossRefPubMed
28.
go back to reference Campbell MK, Snowdon C, Francis D, Elbourne D, McDonald AM, Knight R, Entwistle V, Garcia J, Roberts I, Grant A: Recruitment to randomised trials: strategies for trial enrollment and participation study. The STEPS study. Health Technol Assess. 2007, 11: iii-ix-105CrossRef Campbell MK, Snowdon C, Francis D, Elbourne D, McDonald AM, Knight R, Entwistle V, Garcia J, Roberts I, Grant A: Recruitment to randomised trials: strategies for trial enrollment and participation study. The STEPS study. Health Technol Assess. 2007, 11: iii-ix-105CrossRef
30.
go back to reference Krleza-Jeric K, Chan AW, Dickersin K, Sim I, Grimshaw J, Gluud C: Principles for international registration of protocol information and results from human trials of health related interventions: Ottawa statement (part 1). BMJ. 2005, 330: 956-958. 10.1136/bmj.330.7497.956.CrossRefPubMedPubMedCentral Krleza-Jeric K, Chan AW, Dickersin K, Sim I, Grimshaw J, Gluud C: Principles for international registration of protocol information and results from human trials of health related interventions: Ottawa statement (part 1). BMJ. 2005, 330: 956-958. 10.1136/bmj.330.7497.956.CrossRefPubMedPubMedCentral
31.
go back to reference Blanton S, Morris DM, Prettyman MG, McCulloch K, Redmond S, Light KE, Wolf SL: Lessons learned in participant recruitment and retention: the EXCITE trial. Phys Ther. 2006, 86: 1520-1533. 10.2522/ptj.20060091.CrossRefPubMed Blanton S, Morris DM, Prettyman MG, McCulloch K, Redmond S, Light KE, Wolf SL: Lessons learned in participant recruitment and retention: the EXCITE trial. Phys Ther. 2006, 86: 1520-1533. 10.2522/ptj.20060091.CrossRefPubMed
32.
go back to reference Lachin JM, Lan SP: Termination of a clinical trial with no treatment group difference: the Lupus Nephritis Collaborative Study. Control Clin Trials. 1992, 13: 62-79. 10.1016/0197-2456(92)90030-4.CrossRefPubMed Lachin JM, Lan SP: Termination of a clinical trial with no treatment group difference: the Lupus Nephritis Collaborative Study. Control Clin Trials. 1992, 13: 62-79. 10.1016/0197-2456(92)90030-4.CrossRefPubMed
33.
go back to reference Lopes G, Quesada J, Ahn E, Flores A, Ribeiro A, Rocha-Lima CM: Oxaliplatin and fixed-rate infusional gemcitabine in the second-line treatment of patients with metastatic colon cancer: final results of a Phase II trial prematurely closed as a result of poor accrual. Clin Colorectal Cancer. 2007, 6: 641-645. 10.3816/CCC.2007.n.032.CrossRefPubMed Lopes G, Quesada J, Ahn E, Flores A, Ribeiro A, Rocha-Lima CM: Oxaliplatin and fixed-rate infusional gemcitabine in the second-line treatment of patients with metastatic colon cancer: final results of a Phase II trial prematurely closed as a result of poor accrual. Clin Colorectal Cancer. 2007, 6: 641-645. 10.3816/CCC.2007.n.032.CrossRefPubMed
34.
go back to reference Guihan M, Garber SL, Bombardier CH, Durazo-Arizu R, Goldstein B, Holmes SA: Lessons learned while conducting research on prevention of pressure ulcers in veterans with spinal cord injury. Arch Phys Med Rehabil. 2007, 88: 858-861. 10.1016/j.apmr.2007.03.014.CrossRefPubMed Guihan M, Garber SL, Bombardier CH, Durazo-Arizu R, Goldstein B, Holmes SA: Lessons learned while conducting research on prevention of pressure ulcers in veterans with spinal cord injury. Arch Phys Med Rehabil. 2007, 88: 858-861. 10.1016/j.apmr.2007.03.014.CrossRefPubMed
35.
go back to reference Chan AW, Upshur R, Singh JA, Ghersi D, Chapuis F, Altman DG: Research protocols: waiving confidentiality for the greater good. BMJ. 2006, 332: 1086-1089. 10.1136/bmj.332.7549.1086.CrossRefPubMedPubMedCentral Chan AW, Upshur R, Singh JA, Ghersi D, Chapuis F, Altman DG: Research protocols: waiving confidentiality for the greater good. BMJ. 2006, 332: 1086-1089. 10.1136/bmj.332.7549.1086.CrossRefPubMedPubMedCentral
36.
go back to reference Vittinghoff E, McCulloch CE: Relaxing the rule of ten events per variable in logistic and Cox regression. Am J Epidemiol. 2007, 165: 710-718. 10.1093/aje/kwk052.CrossRefPubMed Vittinghoff E, McCulloch CE: Relaxing the rule of ten events per variable in logistic and Cox regression. Am J Epidemiol. 2007, 165: 710-718. 10.1093/aje/kwk052.CrossRefPubMed
37.
go back to reference von Elm E, Rollin A, Blumle A, Huwiler K, Witschi M, Egger M: Publication and non-publication of clinical trials: longitudinal study of applications submitted to a research ethics committee. Swiss Med Wkly. 2008, 138: 197-203.PubMed von Elm E, Rollin A, Blumle A, Huwiler K, Witschi M, Egger M: Publication and non-publication of clinical trials: longitudinal study of applications submitted to a research ethics committee. Swiss Med Wkly. 2008, 138: 197-203.PubMed
38.
go back to reference Blumle A, Antes G, Schumacher M, Just H, von Elm E: Clinical research projects at a German medical faculty: follow-up from ethical approval to publication and citation by others. J Med Ethics. 2008, 34: e20-10.1136/jme.2008.024521.CrossRefPubMed Blumle A, Antes G, Schumacher M, Just H, von Elm E: Clinical research projects at a German medical faculty: follow-up from ethical approval to publication and citation by others. J Med Ethics. 2008, 34: e20-10.1136/jme.2008.024521.CrossRefPubMed
39.
go back to reference Haidich AB, Ioannidis JP: Effect of early patient enrollment on the time to completion and publication of randomized controlled trials. Am J Epidemiol. 2001, 154: 873-880. 10.1093/aje/154.9.873.CrossRefPubMed Haidich AB, Ioannidis JP: Effect of early patient enrollment on the time to completion and publication of randomized controlled trials. Am J Epidemiol. 2001, 154: 873-880. 10.1093/aje/154.9.873.CrossRefPubMed
40.
go back to reference Haidich AB, Ioannidis JP: Patterns of patient enrollment in randomized controlled trials. J Clin Epidemiol. 2001, 54: 877-883. 10.1016/S0895-4356(01)00353-5.CrossRefPubMed Haidich AB, Ioannidis JP: Patterns of patient enrollment in randomized controlled trials. J Clin Epidemiol. 2001, 54: 877-883. 10.1016/S0895-4356(01)00353-5.CrossRefPubMed
41.
go back to reference Godlee F: Publishing study protocols: making them visible will improve registration, reporting and recruitment. BMC Med Res Methodol. 2001, 2: 4-6. Godlee F: Publishing study protocols: making them visible will improve registration, reporting and recruitment. BMC Med Res Methodol. 2001, 2: 4-6.
42.
go back to reference Sun X, Briel M, Walter SD, Guyatt GH: Is a subgroup effect believable? Updating criteria to evaluate the credibility of subgroup analyses. BMJ. 2010, 340: c117-10.1136/bmj.c117.CrossRefPubMed Sun X, Briel M, Walter SD, Guyatt GH: Is a subgroup effect believable? Updating criteria to evaluate the credibility of subgroup analyses. BMJ. 2010, 340: c117-10.1136/bmj.c117.CrossRefPubMed
43.
go back to reference Dal-Re R, Moher D, Gluud C, Treweek S, Demotes-Mainard J, Carne X: Disclosure of investigators' recruitment performance in multicenter clinical trials: a further step for research transparency. PLoS Med. 2011, 8: e1001149-10.1371/journal.pmed.1001149.CrossRefPubMedPubMedCentral Dal-Re R, Moher D, Gluud C, Treweek S, Demotes-Mainard J, Carne X: Disclosure of investigators' recruitment performance in multicenter clinical trials: a further step for research transparency. PLoS Med. 2011, 8: e1001149-10.1371/journal.pmed.1001149.CrossRefPubMedPubMedCentral
44.
go back to reference Oude Rengerink K, Opmeer BC, Logtenberg SL, Hooft L, Bloemenkamp KW, Haak MC, Oudijk MA, Spaanderman ME, Duvekot JJ, Willekes C: IMproving PArticipation of patients in Clinical Trials--rationale and design of IMPACT. BMC Med Res Methodol. 2010, 10: 85-10.1186/1471-2288-10-85.CrossRefPubMedPubMedCentral Oude Rengerink K, Opmeer BC, Logtenberg SL, Hooft L, Bloemenkamp KW, Haak MC, Oudijk MA, Spaanderman ME, Duvekot JJ, Willekes C: IMproving PArticipation of patients in Clinical Trials--rationale and design of IMPACT. BMC Med Res Methodol. 2010, 10: 85-10.1186/1471-2288-10-85.CrossRefPubMedPubMedCentral
Metadata
Title
Learning from failure - rationale and design for a study about discontinuation of randomized trials (DISCO study)
Authors
Benjamin Kasenda
Erik B von Elm
John You
Anette Blümle
Yuki Tomonaga
Ramon Saccilotto
Alain Amstutz
Theresa Bengough
Jörg Meerpohl
Mihaela Stegert
Kari A O Tikkinen
Ignacio Neumann
Alonso Carrasco-Labra
Markus Faulhaber
Sohail Mulla
Dominik Mertz
Elie A Akl
Dirk Bassler
Jason W Busse
Ignacio Ferreira-González
Francois Lamontagne
Alain Nordmann
Rachel Rosenthal
Stefan Schandelmaier
Xin Sun
Per O Vandvik
Bradley C Johnston
Martin A Walter
Bernard Burnand
Matthias Schwenkglenks
Heiner C Bucher
Gordon H Guyatt
Matthias Briel
Publication date
01-12-2012
Publisher
BioMed Central
Published in
BMC Medical Research Methodology / Issue 1/2012
Electronic ISSN: 1471-2288
DOI
https://doi.org/10.1186/1471-2288-12-131

Other articles of this Issue 1/2012

BMC Medical Research Methodology 1/2012 Go to the issue